Course Provider
Learning Objectives
Upon completion of this activity, participants should be better able to assess current practice patterns to identify facilitators and barriers to the timely identification of patients eligible for CAR T-cell therapy for diffused large B-cell lymphoma (DLBCL) and follicular lymphoma (FL)
Upon completion of this activity, participants should be better able to identify patients eligible for CAR T-cell therapy based on non-Hodgkin lymphoma (NHL) subtype, line of therapy, and patient-specific factors to facilitate optimal treatment
Upon completion of this activity, participants should be better able to integrate patient education strategies to facilitate engagement and early identification of eligible DLBCL and FL patients who would benefit from CAR T-cell treatment